We have shown that treatment of MYC-driven neuroblastoma cells with CX-5461 and Halofuginone causes down-regulation of MYC and MYCN proteins and growth suppression MYC-driven neuroblastoma cell lines in vitro and preclinical models [31,112]. Here, MYC is linked to neuroblastoma.